NVE Corporation 10-Q Summary: Quarter Ended June 30, 2011
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for NVE Corporation, a developer and seller of spintronic devices (nanotechnology relying on electron spin). The report covers the quarterly period ended June 30, 2011 (the first quarter of fiscal year 2012). The company is an accelerated filer incorporated in Minnesota.
Key Financial Metrics
| Metric | Q1 2012 (Ended June 30, 2011) | Q1 2011 (Ended June 30, 2010) |
|---|---|---|
| Total Revenue | $8,213,762 | $7,241,294 |
| Gross Profit | $5,618,170 | $5,165,490 |
| Gross Margin | 68.4% | 71.3% |
| Net Income | $3,439,228 | $3,101,097 |
| Diluted EPS | $0.70 | $0.64 |
| Operating Cash Flow | $5,074,995 | $5,424,535 |
| Cash & Marketable Securities | $67,215,599 | $62,179,707 (as of Mar 31, 2011) |
| Total Assets | $76,641,923 | $71,836,225 (as of Mar 31, 2011) |
| Current Liabilities | $3,130,856 | $1,865,676 (as of Mar 31, 2011) |
Debt & Liquidity: The company reported no long-term debt. Current liabilities increased primarily due to a $1.37 million increase in income taxes payable, as no estimated tax payments were due in the quarter. The company maintains a strong liquidity position with cash and marketable securities representing approximately 86% of total assets.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 13.4% year-over-year, driven by a 13.4% increase in product sales (due to new customers and higher volume) and a 13.7% increase in contract research and development revenue.
- Margin Compression: Gross profit margin decreased from 71.3% to 68.4% due to increased labor costs and a less favorable product sales mix.
- Expense Increase: Total operating expenses rose 14.5%, primarily driven by a 44.8% increase in Research and Development (R&D) expenses attributed to increased product development activities.
- Interest Income: Interest income increased 18.9% to $565,529 due to a larger portfolio of interest-bearing marketable securities.
- Tax Rate: The effective tax rate decreased to 32% from 34% due to lower state and federal effective tax rates.
Outlook, Risks, and Management Commentary
Management Commentary: Management attributes the net income increase of 10.9% to revenue growth and higher interest income, partially offset by higher R&D expenses. The company believes its working capital and cash generated from operations will be adequate for the next 12 months.
Investment Portfolio: The company holds $65.5 million in marketable securities. While there were gross unrealized losses of $94,866 on six corporate and two municipal bonds, management does not consider these other-than-temporarily impaired as all bonds are investment-grade and the company intends to hold them to maturity.
Risks: The filing states there have been no material changes to risk factors from the previous 10-K. Key risks include competition, R&D progress, cost variations, supplier failures, and the inability to obtain new customers or consummate license agreements.
Stock Repurchase: The company has an authorized repurchase plan of up to $2.5 million but did not repurchase any shares during this quarter.
Investor Verification Checklist
- Sustainability of R&D Spend: Verify if the 45% increase in R&D expenses is a one-time project cost or a new baseline for future quarters.
- Product Mix Impact: Assess the long-term impact of the "less favorable product sales mix" on future gross margins.
- Contract Revenue Volatility: Confirm the stability of contract research and development revenue, as management noted it can fluctuate significantly.
- Investment Portfolio Health: Monitor the unrealized losses on the corporate bond portfolio to ensure they do not become realized losses if market conditions deteriorate.
- Customer Concentration: Review the 10-K for details on customer concentration, as revenue growth was driven by "new customers" and "existing customers."